Back to search

University of British Columbia

Development and application of machine learning-based tools for the discovery of small molecule inhibitors of SARS-CoV-2 papain-like protease (PLpro)

Abstract

dc:description

The rapid global spread of the SARS-CoV-2 virus facilitated the development of novel direct-acting antiviral agents (DAAs) targeting the virus’s essential proteins, such as Papain-like protease or PLpro. This enzyme plays a dual role participating in the maturation of viral proteins and in the suppression of the host immune system. In this work, we performed a virtual screening of ultra-large chemical libraries to identify prospective non-covalent PLpro inhibitors. The analysis of active compounds revealed their somewhat limited diversity, which is a recurring theme across publications on the discovery of PLpro ligands. This is likely attributed to the induced-fit nature of the enzyme’s active site which limits the effectiveness of rigid molecular docking protocols. Even with such constraint, we demonstrate that the identified compound VPC-300195 ranks among the top non-covalent PLpro inhibitors discovered through in silico methodologies and reported to date. After discovering an initial set of promising compounds through virtual screening, we developed a deep reinforcement learning-based approach to further optimize the hit molecules. This method modifies the candidate molecule inside of the protein pocket using fragment-based addition and replacement. We optimized the series of VPC-300195 derivatives on multiple parameters including Quantitative Estimate of Druglikeness (QED), Synthetic Accessibility (SA) score, predicted toxicity, and binding free energy. The state of the newly elaborated molecule was estimated using Molecular Mechanics Generalized Born Solvent Accessible Surface Area (MMGBSA) while performing complementary minimization (taking into account the solvent effects and protein dynamics). Taken together, the results of this work laid a foundation for the development of effective non-covalent SARS-CoV-2 inhibitors and provided a potential platform for effective optimization of initial hit compounds using methods of reinforcement learning.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Garland, Olivia
Contributors dc:contributor
  • Cherkasov, Artem

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/87232

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Garland, Olivia. Development and application of machine learning-based tools for the discovery of small molecule inhibitors of SARS-CoV-2 papain-like protease (PLpro). master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/87232